Squarepoint’s OncoSec Medical Incorporated ONCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,365
Closed -$248K 4017
2021
Q1
$248K Buy
+2,365
New +$324K ﹤0.01% 2559
2020
Q3
Sell
-853
Closed -$38K 3024
2020
Q2
$38K Buy
+853
New +$36.3K ﹤0.01% 2127

Other funds holding ONCS

Squarepoint's ONCS Position: Q2 2021 in Review

Squarepoint sold out of OncoSec Medical Incorporated (ONCS) in Q2 2021, closing a stake of 2,365 shares — an estimated $248K sold.

Squarepoint first reported a position in ONCS in Q2 2020 and held it in 2 quarters. The position peaked at $248K in Q1 2021. 35 funds tracked by Wall St. Rank hold ONCS as of Q2 2021.

  • Squarepoint reported no remaining OncoSec Medical Incorporated position as of Q2 2021 after selling out during the quarter.
  • Squarepoint sold 2,365 OncoSec Medical Incorporated shares in Q2 2021, an estimated $248K.
  • Squarepoint first reported a position in OncoSec Medical Incorporated in Q2 2020 and held it in 2 quarters.
  • Squarepoint's OncoSec Medical Incorporated position peaked at $248K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2021.

Based on Squarepoint's 13F filing for Q2 2021, filed 16 Aug 2021.